M
10b5-1 Plan
$ Value
$1.1M
Shares
7,846
Price
$144
Filed
Nov 20
Insider
Name
DELANEY MARK E
Title
SVP & Chief Commercial Officer
CIK
0001955265
Roles
Officer
Transaction Details
Transaction Date
2025-11-18
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. | The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.
Filing Info
DELANEY MARK E's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-11-18 | DGX | M | $1.1M |
| 2025-11-18 | DGX | M | $14K |
| 2025-11-18 | DGX | ▼ | $1.5M |
| 2025-11-18 | DGX | M | $1.1M |
| 2025-11-18 | DGX | M | $14K |
| 2025-10-21 | DGX | A | $3K |
| 2025-07-21 | DGX | L | $3K |
| 2025-05-13 | DGX | ▼ | $153K |
| 2025-05-12 | DGX | ▼ | $154K |
| 2025-04-21 | DGX | L | $4K |
Other Insiders at DGX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CARTER ROBERT B | — | — | 2026-01-28 |
| WENTWORTH TIMOTHY C | — | — | 2026-04-01 |
|
Plewman Patrick
SVP for Diagnostic Services
|
— | $1.2M | 2026-02-10 |
|
Doherty Catherine T.
EVP, Regional Businesses
|
— | $5.4M | 2026-02-13 |